Form D · Biotechnology

Myogenica Inc.

Saint Paul, MN · CIK 0001918814

Offering snapshot reported Mar 28, 2022 · SEC filing

Reported sold
$100K
Offering amount: $2M
Investors reported
1
Form D · investor count
Minimum accepted
$15K
Reported outside-investor minimum
First sale
Feb 24, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$50K$100KMar 22, 2022: $100,000.00Mar 22, 2022Mar 28, 2022: $100,000.00Mar 28, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Minimum accepted$25,000 → $15,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 28, 2022Amendment$100,000$0vs Mar 22, 20221SEC filing
Mar 22, 2022Initial$100,000No comparison1SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-438410

Source: Form D, filed Mar 28, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Paul Allen Hawkins Director, Executive
Michael Kyba Director
Rita Perlingeiro Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
698 Portland Avenue
Saint Paul, MN, 55104